GIC Sells Over $721M Worth of Medline Inc. Stock
Medline Inc.
Subscribe to track MDLN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
🚨 Medline Inc. ($MDLN) - Major Insider Sale
Insider: GIC Private Ltd / Hux Investment Pte. Ltd. (10% Owner) Action: Sold 20,678,630 shares across multiple transactions (Oct 2–6, 2026) Average Price: ~$34.90 Total Transaction Value: $721,644,227.38 Remaining Holdings: 93,679,299 shares (16,453,806 direct + 77,225,493 indirect)
Comprehensive Analysis
Executive Summary
Between October 2 and October 6, 2026, 10% beneficial owners GIC Private Ltd, GIC Special Investments Pte Ltd, and Hux Investment Pte. Ltd. executed a series of large-scale open market sales of Medline Inc. ($MDLN) Class A Common Stock. In total, the reporting persons sold 20,678,630 shares for an aggregate consideration of approximately $721.64 million at weighted-average prices ranging from $34.33 to $35.78 per share.
Transaction Breakdown
- October 2, 2026:
- Direct sale of 2,570,999 shares at a weighted-average price of $35.35 ($90.88M).
- Indirect sale via Hux Investment of 7,146,941 shares at $34.33 ($245.35M).
- October 5, 2026:
- Direct sale of 1,688,690 shares at a weighted-average price of $35.78 ($60.42M).
- October 6, 2026:
- Direct sale of 2,088,987 shares at $35.05 ($73.22M).
- Indirect sale via Hux Investment of 7,183,013 shares at $35.05 ($251.76M).
Ownership Impact
Following these transactions:
- GIC Private Ltd retains direct ownership of 16,453,806 shares.
- Hux Investment Pte. Ltd. indirectly holds 77,225,493 shares.
- Combined retained beneficial ownership stands at 93,679,299 shares, indicating the group remains a significant multi-billion-dollar stakeholder in Medline Inc. despite the sizable liquidity event.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
